Lobbying Activity Report

331-14436

Organization: Boehringer Ingelheim Canada Ltd
Associated registration: 2038-331-27
Lobbying Activity date: 2021-11-25
Arranged a meeting: No
Posted date: 2021-12-01

In-house lobbyists who participated in the lobbying activity: Marc O'Loughlin
Andrew Ransom
Mehmood Alibhai
Senior Public Office Holders who were lobbied in this activity: Mitch Moneo, Assistant Deputy Minister
PLBSD, Health

Dawn Thomas, Associate Deputy Minister
Indigenous Health, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Discuss healthcare improvement partnerships
  • Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
 Indigenous Relations and Reconciliation
To actively promote the contributions and positive impact of pharmaceutical innovation and the innovative pharmaceutical industry in British Columbia and to increase awareness of the value of innovative therapies on the healthcare system. Ensure any changes to pharmaceutical legislation support appropriate government reimbursement of innovative pharmaceuticals. Work with the Ministry of Health regarding public reimbursement of our innovative pharmaceutical products Footnote1
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
 Health Footnote1
 
Senior officer who filed this Lobbying Activity Report: Andrea Sambati
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
 
  1. Footnote1  Indicates new information that was added through a Lobbying Activity Report.
Return to Registration for The Nature Conservancy
Date Modified: